Please assess the completion status of the following clinical trial:

Trial Title: A Study to Evaluate Safety and Tolerability After Oral Dosing of AZD1656 in Healthy Volunteers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Provision of informed consent~* Clinically normal physical findings and laboratory values as judged by the investigator including negative test of Hepatitis B surface antigen, antibodies to HIV virus and antibodies to hepatitis C virus.~Exclusion Criteria:~* Clinically significant illness or clinically relevant trauma, as judged by the investigator, within 2 weeks before the first administration of the Investigational Product~* History of psychiatric or somatic disease/condition that may interfere with the objectives of the study, as judged by the investigator

- Gender: MALE
- Minimum Age: 20 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): 8 increasing oral single doses given to 8 groups (3 on active and 1 on placebo in each group)
- 2 (Type: EXPERIMENTAL): 2 oral doses of AZD1656 given to 2 groups together with food

Based on this trial design, predict the completion outcome and termination type (if applicable).